Ran-Fosinopril · DIN 02294524 · 10 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.Discontinued July 10, 2025 · checked November 19, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ran-Fosinopril · DIN 02294524
Manufacturer: Ranbaxy Pharmaceuticals Canada Inc.; listing date 2010-03-02
Daily cost (source): $0.2178
Health Canada: Cancelled post market since 2025-07-10 · brand RAN-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Ranbaxy pharmaceuticals canada inc. · schedule Prescription
Ran-Fosinopril: Formulary list price $0.22 per unit (the source does not state the unit; exact figure $0.2178). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02294524)
Source record
DIN 02294524: Ran-Fosinopril
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id RAN
Source form: Tab; strength: 10mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2178; ministry $0.2178
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02294524
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77986
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178
Fosinopril · DIN 02459388 · $0.2178
Jamp-Fosinopril · DIN 02331004 · $0.2178
Monopril · DIN 01907107 · not recorded
Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 10, 2025 — choose a marketed DIN from the same-category list.